Nivolumab and ipilimumab therapy in a patient with non-small cell lung cancer with chronic kidney disease
Main Authors: | Hiroaki Satoh, Sou Hattori |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-06-01
|
Series: | Contemporary Oncology |
Subjects: | |
Online Access: | https://www.termedia.pl/Nivolumab-and-ipilimumab-therapy-in-a-patient-with-non-small-cell-lung-cancer-with-chronic-kidney-disease,3,47466,1,1.html |
Similar Items
-
Cost-Effectiveness of Nivolumab Plus Ipilimumab With and Without Chemotherapy for Advanced Non-Small Cell Lung Cancer
by: Szu-Chun Yang, et al.
Published: (2021-12-01) -
Cost-Effectiveness of Nivolumab Plus Ipilimumab as First-Line Therapy in Advanced Non–small-cell Lung Cancer
by: Xuezhi Hao, et al.
Published: (2021-07-01) -
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab vs. Chemotherapy as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
by: Huabin Hu, et al.
Published: (2020-09-01) -
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
by: Xiaomin Wan, et al.
Published: (2021-08-01) -
Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
by: Mary Towner, et al.
Published: (2022-08-01)